Home › Activist investors › Lone Star Value
Campaign activist. Positions and campaigns from Lone Star Value’s SEC filings. Updated November 20, 2026.
No active campaign by this definition (see How to read this).
No current position by this definition.
Campaigns are compiled from SEC filings (13D, proxy contest filings and settlement 8-Ks); campaigns run without SEC filings, e.g. by public letter below the 5% threshold, may not appear.
| Company | Outcome or last status | Date | First filing | Highest stage | Filings | Meeting / votes |
|---|---|---|---|---|---|---|
| Dakota Plains Holdings, Inc.Board seats | No campaign filings in the last 12 months | Aug 23, 2016 | Mar 18, 2016 | Proxy contest filed (preliminary proxy) | latest (4) | — |
| Rentech, Inc. | Settled (agreement with the company) | Apr 28, 2016 | Apr 28, 2016 | — | latest (1) | — |
| Edgewater Technology Inc/De/Board seats | No campaign filings in the last 12 months | Dec 29, 2015 | Oct 26, 2015 | Proxy contest filed | latest (8) | — |
| Enzo Biochem IncBoard seats | No campaign filings in the last 12 months | Dec 11, 2015 | Dec 2, 2015 | Proxy contest filed | latest (2) | — |
Fund votes come from Form N-PX filings, which this site holds from July 1, 2023 (meetings through June 30, 2026; later meetings appear when the managers file their next N-PX); earlier contests and campaigns that settled before a vote are listed under the activist’s campaigns.
No proxy contest has gone to a vote since July 1, 2023.
How each campaign on record ended, as read from the filings: settlements disclosed in the company’s 8-K or the investor’s 13D, contested votes (8-K Item 5.07), withdrawals and 13D amendments below 5%.
| Company | Outcome | Detail | Date | First filing |
|---|---|---|---|---|
| Dakota Plains Holdings, Inc. | No outcome in the filings read | — | Aug 23, 2016 | Mar 18, 2016 |
| Rentech, Inc. | Settlement | agreement with the company | Apr 28, 2016 | Apr 28, 2016 |
| Edgewater Technology Inc/De/ | No outcome in the filings read | — | Dec 29, 2015 | Oct 26, 2015 |
| Enzo Biochem Inc | No outcome in the filings read | — | Dec 11, 2015 | Dec 2, 2015 |
The change in the company’s closing share price from the first trading day on or before the investor’s first Schedule 13D to the latest close, and to 6 and 12 months after it, beside the S&P 500 (SPY) over the same dates. This is a price change after a filing date: it is not attributed to the investor, and it is not the investor’s return. Coverage: 0 of 0 13D positions have prices (the site’s daily price history starts November 10, 2025, and covers only listed tickers it tracks).
Terms of the cooperation agreements, read by rules from the company’s Form 8-K (or the investor’s 13D where it describes the agreement). Each term is quoted from the filing; terms a rule did not find are not listed, so a missing term is not evidence that the agreement lacks it.
“Concurrent with his appointment to the Board, Mr. Rendino was also appointed to the Finance Committee of the Board and the Compensation Committee of the Board.” 8-K, Apr 28, 2016